4 employees
VAXIMM is a vaccine company offers VXM01 targeting tumor vasculature.
2008
$8M
from 2 investors over 2 rounds
Vaximm AG raised $8M on January 12, 2011
Investors: BioMedPartners and Sunstone Life Science Ventures